Publications

Detailed Information

Phthalates Exposure and Attention-Deficit/Hyperactivity Disorder in School-Age Children

DC Field Value Language
dc.contributor.authorKim, Bung-Nyun-
dc.contributor.authorCho, Soo-Churl-
dc.contributor.authorKim, Yeni-
dc.contributor.authorShin, Min-Sup-
dc.contributor.authorKim, Jae-Won-
dc.contributor.authorKim, Hyo-Won-
dc.contributor.authorHong, Yun-Chul-
dc.contributor.authorBhang, Soo-Young-
dc.contributor.authorYang, Young Hee-
dc.contributor.authorYoo, Hee-Jeong-
dc.date.accessioned2012-06-07T01:22:49Z-
dc.date.available2012-06-07T01:22:49Z-
dc.date.issued2009-11-15-
dc.identifier.citationBIOLOGICAL PSYCHIATRY; Vol.66 10; 958-963ko_KR
dc.identifier.issn0006-3223-
dc.identifier.urihttps://hdl.handle.net/10371/76874-
dc.description.abstractBackground: Very few studies have examined the association between attention-deficit/hyperactivity disorder (ADHD) and phthalate exposure in humans. The aim of this study was to investigate the impact of phthalates on symptoms of ADHD in school-age children. Methods: A cross-sectional examination of urine phthalate concentrations was performed, and scores on measures of ADHD symptoms and neuropsychological dysfunction with regard to attention and impulsivity were obtained from 261 Korean children, age 8-11 years. Results: Mono-2-ethylheyl phthalate (MEHP) and mono-2-ethyl-5-oxohexylphthalate (MEOP) for metabolites of Di-2-ethylhexylphthalate (DEHP) and mono-n-butyl phthalate (MNBP) for metabolites of dibutyl phthalate (DBP) were measured in urine samples. The mean concentrations of MEHP, MEOP, and MNBP were 34.0 mu g/dL (SD = 36.3; range: 2.1-386.7),23.4 mu g/dL (SD = 23.0; range:.75-244.8), and 46.7 mu g/L (SD = 21.4; range: 13.2-159.3), respectively. After adjustment for covariates, teacher-rated ADHD scores were significantly associated with DEHP metabolites but not with DBP metabolites. We also found significant relationships between the urine concentrations of metabolites for DBP and the number of omission and commission errors in continuous performance tests (CPT) after adjustment for covariates. Conclusion: The present study showed a strong positive association between phthalate metabolites in urine and symptoms of ADHD among school-age children.ko_KR
dc.language.isoenko_KR
dc.publisherELSEVIER SCIENCE INCko_KR
dc.subjectADHDko_KR
dc.subjectphthalateko_KR
dc.subjectneuropsychologyko_KR
dc.titlePhthalates Exposure and Attention-Deficit/Hyperactivity Disorder in School-Age Childrenko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor김병연-
dc.contributor.AlternativeAuthor조수철-
dc.contributor.AlternativeAuthor김예니-
dc.contributor.AlternativeAuthor신민섭-
dc.contributor.AlternativeAuthor유희정-
dc.contributor.AlternativeAuthor김재원-
dc.contributor.AlternativeAuthor양영희-
dc.contributor.AlternativeAuthor김효원-
dc.contributor.AlternativeAuthor방수영-
dc.contributor.AlternativeAuthor홍윤철-
dc.identifier.doi10.1016/j.biopsych.2009.07.034-
dc.citation.journaltitleBIOLOGICAL PSYCHIATRY-
dc.description.citedreferenceAdriani W, 2009, NEUROSCIENCE, V159, P47, DOI 10.1016/j.neuroscience.2008.11.042-
dc.description.citedreferenceKim Y, 2009, HUM PSYCHOPHARM CLIN, V24, P95, DOI 10.1002/hup.1010-
dc.description.citedreferenceBellinger DC, 2008, BASIC CLIN PHARMACOL, V102, P237, DOI 10.1111/j.1742-7843.2007.00164.x-
dc.description.citedreferenceYang JW, 2008, PROG NEURO-PSYCHOPH, V32, P243, DOI 10.1016/j.pnpbp.2007.08.016-
dc.description.citedreferenceYANG YH, 2008, J KOREAN NEUROPSYCHA, V47, P292-
dc.description.citedreferenceWhite LD, 2007, TOXICOL APPL PHARM, V225, P1, DOI 10.1016/j.taap.2007.08.001-
dc.description.citedreferenceCheon KA, 2007, NEUROPSYCHOPHARMACOL, V32, P1377, DOI 10.1038/sj.npp.1301244-
dc.description.citedreferenceKim JW, 2006, J PSYCHIAT RES, V40, P730, DOI 10.1016/j.jpsychires.2005.11.002-
dc.description.citedreferenceWormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x-
dc.description.citedreferenceSeidman LJ, 2005, BIOL PSYCHIAT, V57, P1263, DOI 10.1016/j.biopsych.2004.11.019-
dc.description.citedreferenceCorton JC, 2005, TOXICOL SCI, V83, P4, DOI 10.1093/toxsci/kfi011-
dc.description.citedreferenceMasuo Y, 2004, REGUL PEPTIDES, V123, P225, DOI 10.1016/j.regpep.2004.05.010-
dc.description.citedreferenceFennell TR, 2004, TOXICOL SCI, V82, P407, DOI 10.1093/toxsci/kfh294-
dc.description.citedreferenceIshido M, 2004, J NEUROCHEM, V91, P69, DOI 10.1111/j.1471-4159.2004.02696.x-
dc.description.citedreferenceKoch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3-
dc.description.citedreferenceMASUO Y, 2004, NEURAL PLAST, V11, P59-
dc.description.citedreferenceJacobson JL, 2003, J PEDIATR, V143, P780, DOI 10.1067/S0022-3476(03)00577-8-
dc.description.citedreferenceCheon KA, 2003, EUR J NUCL MED MOL I, V30, P306, DOI 10.1007/s00259-002-1047-3-
dc.description.citedreferenceLidsky TI, 2003, BRAIN, V126, P5, DOI 10.1093/brain/awg014-
dc.description.citedreferenceStewart PW, 2003, NEUROTOXICOL TERATOL, V25, P11, DOI 10.1016/S0892-0362(02)00320-3-
dc.description.citedreferenceKavlock R, 2002, REPROD TOXICOL, V16, P721-
dc.description.citedreferenceKavlock R, 2002, REPROD TOXICOL, V16, P709-
dc.description.citedreferenceSO YK, 2002, J KOREAN NEUROPSYCHI, V41, P283-
dc.description.citedreferenceMendola P, 2002, MENT RETARD DEV D R, V8, P188, DOI 10.1002/mrdd.10033-
dc.description.citedreferenceCurran S, 2001, MOL PSYCHIATR, V6, P425-
dc.description.citedreferenceBarr CL, 2000, AM J MED GENET, V96, P262-
dc.description.citedreferenceRice D, 2000, ENVIRON HEALTH PERSP, V108, P511-
dc.description.citedreferenceAdams J, 2000, ENVIRON HEALTH PERSP, V108, P535-
dc.description.citedreferenceSHIN MS, 2000, KOREAN J CHILD ADOLE, V11, P91-
dc.description.citedreferenceDougherty DD, 1999, LANCET, V354, P2132-
dc.description.citedreferenceGladen BC, 1999, REPROD TOXICOL, V13, P41-
dc.description.citedreferenceLevitt P, 1998, DRUG ALCOHOL DEPEN, V51, P109-
dc.description.citedreferenceDUPAUL GJ, 1998, ADHD RATING SCALE 4-
dc.description.citedreferenceSWANSON JM, 1998, MOL PSYCHIATR, V3, P370-
dc.description.citedreferenceTabacova S, 1997, ARCH ENVIRON HEALTH, V52, P341-
dc.description.citedreferencePARK KS, 1996, DEV KEDI WISC INDIVI-
dc.description.citedreferenceCOOK EH, 1995, AM J HUM GENET, V56, P993-
dc.description.citedreferenceVORHEES CV, 1994, ENVIRON HEALTH PERSP, V102, P145-
dc.description.citedreferenceGREENBERG LM, 1993, J CHILD PSYCHOL PSYC, V34, P1019-
dc.description.citedreferenceMILLER MW, 1993, ALCOHOL CLIN EXP RES, V17, P304-
dc.description.citedreferencePETIT TL, 1983, NEUROTOXICOLOGY, V4, P79-
dc.description.citedreferenceSHAYWITZ BA, 1976, SCIENCE, V191, P305-
dc.description.citedreferenceKAUFMAN AS, 1976, CONTEMP EDUC PSYCHOL, V1, P180-
dc.description.tc27-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share